MARY VAUGHN: Open Payments
NPI 1073971131 · HURRICANE, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,627 in 103 payments from 16 companies in 2025. Trend: 2023 $2,427 · 2024 $2,446 · 2025 $1,627
Food & beverage: $1,627
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $299 |
| Novartis Pharmaceuticals Corporation | 16 | $230 |
| ABBVIE INC. | 16 | $227 |
| Paratek Pharmaceuticals, Inc. | 10 | $169 |
| AstraZeneca Pharmaceuticals LP | 5 | $145 |
| GlaxoSmithKline, LLC. | 9 | $138 |
| Lilly USA, LLC | 7 | $111 |
| E.R. Squibb & Sons, L.L.C. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $54 |
| Tactile Systems Technology Inc | 1 | $42 |
Products named: LEQVIO, Ozempic, TRELEGY ELLIPTA, NUZYRA, MOUNJARO, QULIPTA, FARXIGA, UBRELVY.
Industry payments across WV — which companies pay providers there.
